Celularity CELU
NASDAQ CELU
$1.60 +0.22 (+15.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celularity (CELU) Interest Coverage Ratio (2025 - 2026)

Updated

Celularity's Interest Coverage Ratio came in at -28.79 for Q1 2026, compared with -4.30 a year earlier.

Analysis

Celularity (CELU) Interest Coverage Ratio (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 25.41
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 10.28
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 7.27
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 5.22
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -42.08
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Celularity 40.27 Mn 32.74 Mn 2.39 Mn -28.79
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -28.79
Mar 31, 2025 -4.30
API Access

Celularity Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=CELU&period=max&api_key=YOUR_API_KEY